0001209191-12-027015.txt : 20120509 0001209191-12-027015.hdr.sgml : 20120509 20120509163605 ACCESSION NUMBER: 0001209191-12-027015 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120507 FILED AS OF DATE: 20120509 DATE AS OF CHANGE: 20120509 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 BUSINESS PHONE: 6165776000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kelly Lisa CENTRAL INDEX KEY: 0001349077 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 12826243 MAIL ADDRESS: STREET 1: 125 SPRING STREET CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 doc4.xml FORM 4 SUBMISSION X0305 4 2012-05-07 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001349077 Kelly Lisa C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST CAMBRIDGE MA 02139 0 1 0 0 SVP, Human Resources Common Stock 2012-05-07 4 M 0 28593 32.16 A 57168 D Common Stock 2012-05-07 4 M 0 3813 32.16 A 60981 D Common Stock 2012-05-07 4 S 0 16242 55.00 D 44739 D Common Stock 2012-05-07 4 S 0 7187 52.13 D 37552 D Common Stock 2012-05-07 4 S 0 14297 57.50 D 23255 D Common Stock 1667 I 401(k) Stock Option 32.16 2012-05-07 4 M 0 28593 0.00 D 2008-10-24 2018-07-23 Common Stock 28593 1907 D Stock Option 18.93 2012-05-07 4 M 0 3813 0.00 D 2018-02-06 Common Stock 3813 0 D Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan under Rule 10b5-1. Fully vested. David T. Howton, Attorney-In-Fact 2012-05-09